Abstract
The 3′-ends of both prokaryotic and eukaryotic RNA can be polyadenylated and the effect of polyadenylation is known to increase the stability of transcripts in eukaryotes, whereas it promotes instability in prokaryotes. RNAs are considered as key effectors of virulence mechanisms, since they are directly involved in regulatory pathways in pathogenic bacteria. Deadenylation of RNA is thus an important control point and rate-limiting step of its turnover. RNase AS is a novel identified protein of Mycobacterium tuberculosis, which dramatically hampers mycobacterial virulence in vivo, with a mechanism which is still to be fully defined. Phylogenetic analysis identifies orthologs of RNase AS in all mycobacteria. However, functional data only recently clarified that RNase AS is an exo-ribonuclease, which is highly specific in degrading polyadenylate sequences of RNA. This Review summarizes the current knowledge on structure and function of RNase AS and underscores its role in the process of RNA maturation. An overall description of all mycobacterial ribonucleases hitherto characterized is also provided.
Keywords: Function, ribonucleases, structure, tuberculosis.
Current Medicinal Chemistry
Title:Structure and Function of RNase AS: A Novel Virulence Factor From Mycobacterium tuberculosis
Volume: 22 Issue: 14
Author(s): Maria Romano, Flavia Squeglia and Rita Berisio
Affiliation:
Keywords: Function, ribonucleases, structure, tuberculosis.
Abstract: The 3′-ends of both prokaryotic and eukaryotic RNA can be polyadenylated and the effect of polyadenylation is known to increase the stability of transcripts in eukaryotes, whereas it promotes instability in prokaryotes. RNAs are considered as key effectors of virulence mechanisms, since they are directly involved in regulatory pathways in pathogenic bacteria. Deadenylation of RNA is thus an important control point and rate-limiting step of its turnover. RNase AS is a novel identified protein of Mycobacterium tuberculosis, which dramatically hampers mycobacterial virulence in vivo, with a mechanism which is still to be fully defined. Phylogenetic analysis identifies orthologs of RNase AS in all mycobacteria. However, functional data only recently clarified that RNase AS is an exo-ribonuclease, which is highly specific in degrading polyadenylate sequences of RNA. This Review summarizes the current knowledge on structure and function of RNase AS and underscores its role in the process of RNA maturation. An overall description of all mycobacterial ribonucleases hitherto characterized is also provided.
Export Options
About this article
Cite this article as:
Romano Maria, Squeglia Flavia and Berisio Rita, Structure and Function of RNase AS: A Novel Virulence Factor From Mycobacterium tuberculosis, Current Medicinal Chemistry 2015; 22 (14) . https://dx.doi.org/10.2174/0929867322666150417125301
DOI https://dx.doi.org/10.2174/0929867322666150417125301 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of Contrast-enhanced Contemporaneous <sup>18</sup>F-FDG PET/CT on Semi Quantification Uptake Value Using Third Party Viewing Workstation
Recent Patents on Medical Imaging Pulmonary Drug Delivery: A Role for Polymeric Nanoparticles?
Current Topics in Medicinal Chemistry Nanotechnology as a Promising Strategy for Anticancer Drug Delivery
Current Drug Delivery Target Product Selection - Where Can Molecular Pharming Make the Difference?
Current Pharmaceutical Design Graphical Abstracts
Letters in Organic Chemistry Transition States and Inhibitors of the Purine Nucleoside Phosphorylase Family
Current Topics in Medicinal Chemistry Small Molecules Modulating Biogenesis or Processing of microRNAs with Therapeutic Potentials
Current Medicinal Chemistry Resistant Tuberculosis: the Latest Advancements of Second-line Antibiotic Inhalation Products
Current Pharmaceutical Design Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
Current Pharmaceutical Design Sepsis: Links between Pathogen Sensing and Organ Damage
Current Pharmaceutical Design Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy Carbohydrate based Potential Chemotherapeutic Agents: Recent Developments and their Scope in Future Drug Discovery
Mini-Reviews in Medicinal Chemistry Detection of Non-Tuberculosis Mycobacteria by Real Time PCR
Anti-Infective Agents Ligand Docking and Structure-based Virtual Screening in Drug Discovery
Current Topics in Medicinal Chemistry Self-Adjuvanting Lipopeptide Vaccines
Current Medicinal Chemistry Coffee and Depression: A Short Review of Literature
Current Pharmaceutical Design Synthesis, In vitro and In silico Studies of Benzothiazole Azo-Ester Derivatives as Anti-TB Agents
Anti-Infective Agents Subject Index To Volume 7
Current Drug Targets New Antifolate Inhibitors for Mycobacterium avium
Medicinal Chemistry The Long Pentraxin PTX3, a Soluble Pattern Recognition Receptor Involved in Innate Immunity,Inflammation and Female Fertility
Current Immunology Reviews (Discontinued)